Skip to search formSkip to main contentSkip to account menu

mercurascan

Known as: hydroxymercurifluorescein 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

FluoresceinsOrganomercury Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Evaluation of Radiopharmaceuticals Sequestered by Ac utely
Eighteen radiopharmaceuticals were screened in a small-animal model as potential infarct-localizing agents. Twelve of the 18… 
1981
1981
Different efficiency of mercurascan in allograft survival prolongation in male and female mice.
The efficiency of mercurascan on prolongation of skin allograft survival was found to depend on the sex of experimental animals… 
1980
1980
Effect of Mercurascan on sodium transport in frog skin and bladder.
The authors studied the effect of Mercurascan (MSC) (a hydroxy- mercury derivative of fluorescein) on electrical parameters… 
1980
1980
Quantitative evaluation of the development of isoprenaline-induced heart lesions.
The development of heart lesions induced by isoprenaline (ISO) was quantitatively evaluated by 203Hg-Mercurascan (MSC) which was… 
1977
1977
Radiopharmaceuticals for acutely damaged myocardium. II: Synthesis and evaluation of [203Hg] hydroxymercurifluoresceins.
Six [203Hg] hydroxymercurifluoresceins were prepared by two methods and compared with [3H] fluorescein, [131I] rose bengal, and… 
1977
1977
Studies on isoprenaline-induced myocardial lesions 1. Quantitative evaluation by Mercurascan uptake
SummaryFor the quantitative evaluation of myocardial damage induced by isoprenaline (ISO) a method based on the uptake of203Hg… 
1977
1977
Myocardial infarct imaging agents. III. Synthesis and evaluation of [203Hg] hydroxymercuriphthaleins.
Four Hg-203-mercurated phthaleins were prepared, purified, and compared with [203Hg] mercuric nitrate, [3H] phenolphthalein… 
1976
1976
Evaluation of radiopharmaceuticals sequestered by acutely damaged myocardium.
Eighteen radiopharmaceuticals were screened in a small-animal model as potential infarct-localizing agents. Twelve of the 18… 
1975
1975
Studies on the therapeutic use of Mercurascar. Part III. Influence of Mercurascan on some metabolic changes in experimental myocardial ischaemia in dogs. Section I: Energetic and ionic metabolism.
In experimental studies on dogs, the authors investigated the effect of small does of mercurascan (MSC) on metabolism of the… 
1967
1967
Geschwindigkeit der selektiven Akkumulation von Mercurascan-203 im geschädigten Muskel und im ischämischen Myokard
The authors demonstrate that a hydroxy derivative of fluorescein — Mercurascan 203 — very rapidly and selectively accumulates in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)